Clinical Trials List
Protocol NumberCENA731D2320/CENA713D2320E1
Not yet recruiting
2003-11-01 - 2005-08-31
Phase III
Terminated3
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
陳獻宗
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
1040 participants
